NUTX
Nutex Health Inc
218.40$
-2.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.7% | 22.8% | 24.8% | 27.0% | 27.3% | 44.6% | 52.7% | 56.2% | 61.4% | 58.7% | 60.5% | 60.7% | |
| 5.6% | 5.5% | 7.4% | 9.7% | 10.7% | 6.7% | 11.1% | 11.5% | 17.2% | 20.2% | 21.7% | 21.3% | |
| 5.6% | 5.5% | 7.4% | 9.7% | 10.7% | 6.7% | 11.1% | – | 17.2% | 20.2% | 21.7% | 21.3% | |
| 11.4% | 15.8% | 16.3% | 15.4% | 14,309.5% | 36.0% | 39.3% | 42.2% | 40.2% | 35.4% | 35.5% | 37.0% | |
| 0.6% | 0.9% | 0.7% | 0.7% | 0.5% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.5% | 0.4% | |
| 3.7% | 4.3% | 4.2% | 3.3% | 3,174.2% | 2.1% | 1.8% | 1.7% | 1.4% | 1.5% | 1.5% | 1.4% | |
| 4.5% | 5.2% | 5.0% | 3.8% | 3.6% | 2.4% | 2.0% | 1.8% | 2.2% | 2.3% | 2.2% | 2.1% | |
| 78.1% | 80.1% | 80.2% | 80.6% | 81.8% | 69.2% | 63.9% | 59.9% | 54.6% | 53.9% | 53.8% | 47.4% | |
| 14.0% | 14.6% | 14.8% | 17.0% | 15.4% | 21.5% | 23.2% | 23.2% | 19.2% | 17.2% | 19.3% | 12.2% | |
| 6.0% | 5.0% | 4.5% | 5.8% | 4,064.4% | 4.2% | 4.1% | – | 3.4% | 2.5% | 2.8% | 1.9% | |
| 3.7% | 6.3% | 6.0% | 5.6% | 2.4% | 2.1% | 3.3% | 3.6% | 5.1% | 5.3% | 5.3% | 1.0% | |
| 4.0% | 6.6% | 6.5% | 5.3% | 6.1% | 3.4% | 2.9% | 2.4% | 2.7% | 3.2% | 2.5% | 3.2% | |
| 18.7% | 15.4% | 15.6% | 14.9% | 18.2% | 22.3% | 25.9% | 28.0% | 32.9% | 35.9% | 36.2% | 40.9% | |
| -78.7% | -102.7% | -101.3% | -97.0% | -95.5% | -54.5% | -44.9% | -42.0% | -30.9% | -31.2% | -25.0% | -18.0% | |
| 0.9% | 1.1% | 1.1% | 1.2% | 1.7% | 0.8% | 0.8% | 0.8% | 0.7% | 0.8% | 0.7% | 0.7% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.